Review

Diagnosis of Medication-Related Osteonecrosis of the Jaw and Alternative Treatment Methods

Volume: 28 Number: 2 June 30, 2025
TR EN

Diagnosis of Medication-Related Osteonecrosis of the Jaw and Alternative Treatment Methods

Abstract

There is currently no specific evidence regarding the pathogenesis of MRONJ and no definitively accepted treatment. Inhibition of bone remodeling is thought to lead to reduced mechanical damage and the resulting accumulation of areas of bone necrosis. When used in therapeutic doses, bisphosphonates inhibit the resorptive activity of osteoclasts, while stimulating the differentiation and bone deposition of osteoblasts. As a result, the bone regeneration mechanism is impaired and the risk of avascular necrosis increases as a result of decreased bone remodeling. Bone resorption markers type I Collagen (Ctx) C-Terminal Telopeptide, Type I Collagen (NTX) N-Telopeptide, Tetrate Resistance Acid Phosphatase Isoform 5b (TRACP 5b), Nuclear Receptor Activator (RANKL) / Osteoprotegerin (OPG), Total Alkaline Phosphatase It has been reported that BRONJ is diagnosed by examining (Talp), Bone Specific Alkaline Phosphatase, Bone Sialoprotein, Pyridnoline, Deoxypyridnoline, Hydroxyproline values. CT is considered a standard method in the evaluation of MRONJ. Treatment of medication-induced osteonecrosis of the jaw basically aims to relieve pain, control secondary infection in soft and hard tissues, and minimize the progression of bone necrosis. Alternative treatment methods for MRONJ such as parathormone, platelet-rich plasma, laser applications, ozone treatment, use of bone morphogenic proteins, pentoxifylline, and surgical debridement guided by fluorescent staining method are also mentioned. The drugs that may be alternatıve to bıphosphonates are Denosumab, Strontıum Ranelate (Sr), Teriparatide, Edta, Stromal Vascular Fractıon Cells (Svf) but further studies are needed to be accepted as a definitive protocol. Despite the complications of bisphosphonate group drugs, their use is widespread and increasing due to their numerous indications. Informing dentists about the mechanism of bisphosphonate-derived drugs, denosumab and anti-angiogenic drugs the treatment of MRONJ and alternative drugs to these group drugs are important for the management of complications that develop due to these drugs.

Keywords

References

  1. 1. Sabri H, Barootchi S, Heck T, Wang HL. Single‐rooted extraction socket classification: A systematic review and proposal of a new classification system based on morphologic and patient‐related factors. J Esthet Restor Dent. 2023;35:168-182.
  2. 2. Smeets R, Matthies L, Windisch P, Gosau M, Jung R, Brodala N, Stefanini M, Kleinheinz J, Payer M, Henningsen A, Al-Nawas B, Knipfer C. Horizontal augmentation techniques in the mandible: a systematic review. Int J Implant Dent. 2022;8:23.
  3. 3. Artzi Z. Lateral augmentation of the jaw by the split expansion ridge technique. A critical review. Periodontol 2000. 2023;93:205-220.
  4. 4. Nunes M, de Araújo Nobre M, Camargo V. All-on-4 Hybrid with Extra-Long Transnasal Implants: Descriptions of the Technique and Short-Term Outcomes in Three Cases. J Clin Med. 2024;13:3348.
  5. 5. Yu Z, Guo H, Han W, Jiang X, Lin Y. Peri‐zygomatic complications on zygomatic implants with or without penetrating the external surface of zygoma: A 2‐year retrospective study. Clin Implant Dent Relat Res. 2024;26:197-205.
  6. 6. Young L Jr, Michel JD, Moore DJ. A twenty-year evaluation of subperiosteal implants. J Prosthet Dent. 1983;49(5):690-694.
  7. 7. Flynn HE, Natiella JR, Meenaghan MA, Carter JM. The unilateral subperiosteal implant: a clinical technique evolving from experimental studies. J Prosthet Dent. 1982;48:82-85.
  8. 8. Mommaerts MY. Evolutionary steps in the design and biofunctionalization of the additively manufactured sub-periosteal jaw implant 'AMSJI' for the maxilla. Int J Oral Maxillofac Surg. 2019;48:108-114.

Details

Primary Language

English

Subjects

Oral and Maxillofacial Surgery , Oral and Maxillofacial Radiology , Oral Medicine and Pathology

Journal Section

Review

Publication Date

June 30, 2025

Submission Date

January 4, 2025

Acceptance Date

January 15, 2025

Published in Issue

Year 2025 Volume: 28 Number: 2

EndNote
Yılmaz A, Arı I, Samunahmetoğlu E, Hürmüzlü S, Çetiner S (June 1, 2025) Diagnosis of Medication-Related Osteonecrosis of the Jaw and Alternative Treatment Methods. Cumhuriyet Dental Journal 28 2 278–286.

Cumhuriyet Dental Journal (Cumhuriyet Dent J, CDJ) is the official publication of Cumhuriyet University Faculty of Dentistry. CDJ is an international journal dedicated to the latest advancement of dentistry. The aim of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of dentistry. First issue of the Journal of Cumhuriyet University Faculty of Dentistry was published in 1998. In 2010, journal's name was changed as Cumhuriyet Dental Journal. Journal’s publication language is English.


CDJ accepts articles in English. Submitting a paper to CDJ is free of charges. In addition, CDJ has not have article processing charges.

Frequency: Four times a year (March, June, September, and December)

IMPORTANT NOTICE

All users of Cumhuriyet Dental Journal should visit to their user's home page through the "https://dergipark.org.tr/tr/user" " or "https://dergipark.org.tr/en/user" links to update their incomplete information shown in blue or yellow warnings and update their e-mail addresses and information to the DergiPark system. Otherwise, the e-mails from the journal will not be seen or fall into the SPAM folder. Please fill in all missing part in the relevant field.

Please visit journal's AUTHOR GUIDELINE to see revised policy and submission rules to be held since 2020.